Literature DB >> 5807469

A study of plasma potassium and electrocardiographic changes after a single dose of succinylcholine.

W Evers, G B Racz, A B Dobkin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5807469     DOI: 10.1007/bf03004455

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


× No keyword cloud information.
  53 in total

1.  EFFECTS OF POTASSIUM ON AUTOMATICITY AND CONDUCTION OF CANINE HEARTS.

Authors:  M VASSALLE; K GREENSPAN; S JOMAIN; B F HOFFMAN
Journal:  Am J Physiol       Date:  1964-08

2.  Effects of intravenously administered succinyldicholine on cardiac rate, rhythm, and arterial blood pressure in anesthetized man.

Authors:  C H WILLIAMS; S DEUTSCH; H W LINDE; J W BULLOUGH; R D DRIPPS
Journal:  Anesthesiology       Date:  1961 Nov-Dec       Impact factor: 7.892

3.  Danger of suxamethonium and endotracheal intubation in anaesthesia for burns.

Authors:  G H BUSH; H A GRAHAM; A H LITTLEWOOD; L B SCOTT
Journal:  Br Med J       Date:  1962-10-27

4.  BURN MORTALITY AND THE ANAESTHETIST.

Authors:  T J MCCAUGHEY
Journal:  Can Anaesth Soc J       Date:  1963-09

5.  ELEVATION OF PLASMA HISTAMINE LEVELS IN THE DOG FOLLOWING ADMINISTRATION OF MUSCLE RELAXANTS, OPIATES AND MACROMOLECULAR POLYMERS.

Authors:  W L THOMPSON; R P WALTON
Journal:  J Pharmacol Exp Ther       Date:  1964-01       Impact factor: 4.030

6.  Effect of suxamethonium on cardiac rhythm.

Authors:  K G LUPPRIAN; H C CHURCHILL-DAVIDSON
Journal:  Br Med J       Date:  1960-12-17

7.  [Influence of potassium on electrocardiographic effects induced by acetylcholine. Research on the isolated heart of the rabbit].

Authors:  M Palazzoadriano; A Raineri; A Battaglia; G Barone
Journal:  Minerva Cardioangiol       Date:  1965-09       Impact factor: 1.347

8.  Serum potassium changes during induction of anaesthesia.

Authors:  W F List
Journal:  Br J Anaesth       Date:  1967-06       Impact factor: 9.166

9.  Muscular origin of elevated plasma potassium during exercise.

Authors:  K H Kilburn
Journal:  J Appl Physiol       Date:  1966-03       Impact factor: 3.531

10.  [Mechanism of succinylcholine SCC)-induced arrhythmia].

Authors:  K Takahashi
Journal:  Masui       Date:  1965-10
View more
  9 in total

1.  Changes in plasma potassium and calcium levels and in the electrocardiogram after a single dose of succinylcholine preceded by d-tubocurarine.

Authors:  W Evers; G B Racz; A A Levy
Journal:  Can Anaesth Soc J       Date:  1976-07

Review 2.  Hyperkalaemia following succinylcholine administration in neurological disorders: a review.

Authors:  R B Smith
Journal:  Can Anaesth Soc J       Date:  1971-03

3.  Succinylcholine induced hyperkalaemia in patients with strabismus.

Authors:  P E Berkebile; H H Pfaeffle; R B Smith
Journal:  Can Anaesth Soc J       Date:  1973-03

4.  Cardiac arrhythmias following the administration of succinylcholine.

Authors:  R B Smith
Journal:  Anesth Prog       Date:  1971 Jan-Feb

Review 5.  Drug-induced electrolyte abnormalities.

Authors:  E P Brass; W L Thompson
Journal:  Drugs       Date:  1982-09       Impact factor: 9.546

Review 6.  Adverse effects of depolarising neuromuscular blocking agents. Incidence, prevention and management.

Authors:  W J Book; M Abel; J B Eisenkraft
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606

Review 7.  Potassium and anaesthesia.

Authors:  J E Tetzlaff; J F O'Hara; M T Walsh
Journal:  Can J Anaesth       Date:  1993-03       Impact factor: 5.063

8.  Serum potassium after enflurane-succinylcholine induction of anesthesia in children receiving rectal midazolam as premedication.

Authors:  J A Roelofse; J E Hartshorne
Journal:  Anesth Prog       Date:  1992

9.  Supramolecular therapeutics to treat the side effects induced by a depolarizing neuromuscular blocking agent.

Authors:  Xiangjun Zhang; Qian Cheng; Lanlan Li; Liqing Shangguan; Chenwen Li; Shengke Li; Feihe Huang; Jianxiang Zhang; Ruibing Wang
Journal:  Theranostics       Date:  2019-05-18       Impact factor: 11.556

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.